Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Neuroimaging of rapid eye movement sleep behavior disorder: transcranial ultrasound, single-photon emission computed tomography, and positron emission tomography scan data.

Miyamoto M, Miyamoto T.

Sleep Med. 2013 Aug;14(8):739-43. doi: 10.1016/j.sleep.2013.03.004. Epub 2013 May 3. Review.

PMID:
23648146
2.

Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder.

Rupprecht S, Walther B, Gudziol H, Steenbeck J, Freesmeyer M, Witte OW, Günther A, Schwab M.

Sleep Med. 2013 Nov;14(11):1064-70. doi: 10.1016/j.sleep.2013.06.008. Epub 2013 Aug 13.

PMID:
23948220
3.

Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

Iranzo A, Lomeña F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, Molinuevo JL, Serradell M, Duch J, Pavía J, Gallego J, Seppi K, Högl B, Tolosa E, Poewe W, Santamaria J; Sleep Innsbruck Barcelona (SINBAR) group.

Lancet Neurol. 2010 Nov;9(11):1070-7. doi: 10.1016/S1474-4422(10)70216-7. Epub 2010 Sep 16. Erratum in: Lancet Neurol. 2010 Nov;9(11):1045.

PMID:
20846908
4.

Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.

Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, Sanchez-Valle R, Vilaseca I, Lomeña F, Vilas D, Lladó A, Gaig C, Santamaria J.

Lancet Neurol. 2013 May;12(5):443-53. doi: 10.1016/S1474-4422(13)70056-5. Epub 2013 Apr 3.

PMID:
23562390
5.

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.

Schenck CH, Montplaisir JY, Frauscher B, Hogl B, Gagnon JF, Postuma R, Sonka K, Jennum P, Partinen M, Arnulf I, Cochen de Cock V, Dauvilliers Y, Luppi PH, Heidbreder A, Mayer G, Sixel-Döring F, Trenkwalder C, Unger M, Young P, Wing YK, Ferini-Strambi L, Ferri R, Plazzi G, Zucconi M, Inoue Y, Iranzo A, Santamaria J, Bassetti C, Möller JC, Boeve BF, Lai YY, Pavlova M, Saper C, Schmidt P, Siegel JM, Singer C, St Louis E, Videnovic A, Oertel W.

Sleep Med. 2013 Aug;14(8):795-806. doi: 10.1016/j.sleep.2013.02.016. Epub 2013 Jul 22. Erratum in: Sleep Med. 2014 Jan;15(1):157.

PMID:
23886593
6.

Hippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorder.

Dang-Vu TT, Gagnon JF, Vendette M, Soucy JP, Postuma RB, Montplaisir J.

Neurology. 2012 Dec 11;79(24):2302-6. doi: 10.1212/WNL.0b013e318278b658. Epub 2012 Oct 31.

7.

Longitudinal study of regional cerebral blood flow in elderly patients with idiopathic rapid eye movement sleep behavior disorder.

Sakurai H, Hanyu H, Inoue Y, Kanetaka H, Nakamura M, Miyamoto T, Sasai T, Iwamoto T.

Geriatr Gerontol Int. 2014 Jan;14(1):115-20. doi: 10.1111/ggi.12068. Epub 2013 Apr 15.

PMID:
23586530
8.

Transcranial sonography in relation to SPECT and MIBG.

Kajimoto Y, Miwa H, Kondo T.

Int Rev Neurobiol. 2010;90:48-62. doi: 10.1016/S0074-7742(10)90004-4. Review.

PMID:
20692493
9.

Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT.

Unger MM, Möller JC, Stiasny-Kolster K, Mankel K, Berg D, Walter U, Hoeffken H, Mayer G, Oertel WH.

Mov Disord. 2008 Mar 15;23(4):596-9. doi: 10.1002/mds.21908.

PMID:
18175346
10.
11.

Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.

Iranzo A, Stockner H, Serradell M, Seppi K, Valldeoriola F, Frauscher B, Molinuevo JL, Vilaseca I, Mitterling T, Gaig C, Vilas D, Santamaria J, Högl B, Tolosa E, Poewe W.

Mov Disord. 2014 Dec;29(14):1774-80. doi: 10.1002/mds.26055. Epub 2014 Nov 10.

PMID:
25384461
12.

Functional imaging in pre-motor Parkinson's disease.

Arnaldi D, Morbelli S, Picco A, Ferrara M, Buschiazzo A, Famà F, De Carli F, Nobili F.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):366-75. Epub 2014 Nov 4. Review.

PMID:
25366709
13.

Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.

Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE.

Mov Disord. 2001 Jul;16(4):622-30.

PMID:
11481685
14.

123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.

Miyamoto T, Miyamoto M, Suzuki K, Nishibayashi M, Iwanami M, Hirata K.

Sleep. 2008 May;31(5):717-23.

15.

Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder.

Miyamoto M, Miyamoto T, Iwanami M, Muramatsu S, Asari S, Nakano I, Hirata K.

Sleep Med. 2012 Jan;13(1):102-6. doi: 10.1016/j.sleep.2011.03.024. Epub 2011 Oct 26.

PMID:
22033122
17.

[Historical overview of REM sleep behavior disorder in relation to its pathophysiology].

Tachibana N.

Brain Nerve. 2009 May;61(5):558-68. Review. Japanese.

PMID:
19514516
18.

Primary visual cortical metabolism and rapid eye movement sleep behavior disorder in dementia with Lewy bodies.

Chiba Y, Iseki E, Fujishiro H, Ota K, Kasanuki K, Arai H, Hirayasu Y, Sato K.

Psychiatry Clin Neurosci. 2014 Feb;68(2):137-44. doi: 10.1111/pcn.12101. Epub 2013 Oct 30.

19.

Regional cerebral blood flow changes in patients with idiopathic REM sleep behavior disorder.

Hanyu H, Inoue Y, Sakurai H, Kanetaka H, Nakamura M, Miyamoto T, Sasai T, Iwamoto T.

Eur J Neurol. 2011 May;18(5):784-8. doi: 10.1111/j.1468-1331.2010.03283.x. Epub 2010 Dec 12.

PMID:
21143707
20.

Imaging neurodegeneration in Parkinson's disease.

Pavese N, Brooks DJ.

Biochim Biophys Acta. 2009 Jul;1792(7):722-9. doi: 10.1016/j.bbadis.2008.10.003. Epub 2008 Oct 17. Review.

Items per page

Supplemental Content

Write to the Help Desk